loadpatents
name:-0.020174026489258
name:-0.020122051239014
name:-0.0057299137115479
Felts; Andrew S. Patent Filings

Felts; Andrew S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Felts; Andrew S..The latest application filed is for "indazole compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction".

Company Profile
5.21.19
  • Felts; Andrew S. - Brentwood TN
  • Felts; Andrew S. - Nashville TN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 11,427,573 - Conn , et al. August 30, 2
2022-08-30
Indazole Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20220259190 - Conn; P. Jeffrey ;   et al.
2022-08-18
Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 11,319,304 - Conn , et al. May 3, 2
2022-05-03
Indazole Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20200291019 - Conn; P. Jeffrey ;   et al.
2020-09-17
Pyridine Quinoline Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20200165232 - Conn; P. Jeffrey ;   et al.
2020-05-28
4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators
Grant 10,538,491 - Conn , et al. Ja
2020-01-21
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 10,508,105 - Conn , et al. Dec
2019-12-17
Positive allosteric modulators of the muscarinic acetylcholine receptor M4
Grant 10,342,782 - Lindsley , et al. July 9, 2
2019-07-09
Indazole Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20190055225 - Conn; P. Jeffrey ;   et al.
2019-02-21
Negative Allosteric Modulators Of Metabotropic Glutamate Receptor 2
App 20180072674 - Conn; P. Jeffrey ;   et al.
2018-03-15
Positive Allosteric Modulators Of The Muscarinic Acetylcholine Receptor M4
App 20180028501 - Lindsley; Craig W. ;   et al.
2018-02-01
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5
Grant 9,844,542 - Emmitte , et al. December 19, 2
2017-12-19
Substituted 4-alkoxypicolinamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20170247366 - EMMITTE; Kyle A. ;   et al.
2017-08-31
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
Grant 9,550,778 - Emmitte , et al. January 24, 2
2017-01-24
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
Grant 9,533,982 - Conn , et al. January 3, 2
2017-01-03
Substituted Imidazopyridine And Triazolopyridine Compounds As Negative Allosteric Modulators Of Mglur5
App 20160289227 - Emmitte; Kyle A. ;   et al.
2016-10-06
Negative Allosteric Modulators Of Metabotropic Glutamate Receptor 2
App 20160214940 - Conn; P. Jeffrey ;   et al.
2016-07-28
Negative allosteric modulators of metabotropic glutamate receptor 2
Grant 9,382,208 - Conn , et al. July 5, 2
2016-07-05
Substituted 6-aryl-imidazopyridine And 6-aryl-triazolopyridine Carboxamide Analogs As Negative Allosteric Modulators Of Mglur5
App 20160096833 - Emmitte; Kyle A. ;   et al.
2016-04-07
Substituted Bicyclic Heteroaryl Carboxamide Analogs As Mglur5 Negative Allosteric Modulators
App 20150266866 - Conn; P. Jeffrey ;   et al.
2015-09-24
6-alkyl-N-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
Grant 9,085,562 - Conn , et al. July 21, 2
2015-07-21
Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
Grant 8,796,295 - Conn , et al. August 5, 2
2014-08-05
6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20140206707 - Conn; P. Jeffrey ;   et al.
2014-07-24
Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
Grant 8,598,345 - Conn , et al. December 3, 2
2013-12-03
Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
Grant 8,569,308 - Conn , et al. October 29, 2
2013-10-29
Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
Grant 8,501,757 - Conn , et al. August 6, 2
2013-08-06
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
Grant 8,168,656 - Marnett , et al. May 1, 2
2012-05-01
Substituted Heteroarylamine Carboxamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20110172247 - Conn; P. Jeffrey ;   et al.
2011-07-14
Substituted Heteroarylamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20110172248 - Conn; P. Jeffrey ;   et al.
2011-07-14
Substituted Phenylamine Carboxamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20110166158 - Conn; P. Jeffrey ;   et al.
2011-07-07
Substituted Benzamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same
App 20110152299 - Conn; P. Jeffrey ;   et al.
2011-06-23
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
App 20090118290 - Marnett; Lawrence J. ;   et al.
2009-05-07
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
Grant 7,491,744 - Marnett , et al. February 17, 2
2009-02-17
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
App 20050250839 - Marnett, Lawrence J. ;   et al.
2005-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed